Announcements Trials
Browse Landscape

Phase

Phase 2 39Phase 3 25Phase 1 19Phase 1/2 15Phase 4 7Phase 2/3 3Phase NA 1Phase EARLY_PHASE1 1

Status

Unknown 5Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 3

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Idarubicin × Clear all
NCT00151242 2017-09-20

Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

University of Ulm

Phase 2/3 Completed
920 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00909168 2014-05-06

MYFLAI07

University Hospital, Udine, Italy

Phase 2/3 Completed
130 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01015196 2009-11-18

AML2001

Nantes University Hospital

Phase 2/3 Completed
832 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡